Introduction to JMIR Diabetes
JMIR Diabetes is a modern platform that combines digital health strategies and emerging technologies to tackle the diabetes epidemic. In this section, we will explore JMIR’s commitment to leveraging innovative tools to improve diabetes care. Additionally, we will examine the platform’s audience and open-access policy, which puts its cutting-edge research in the hands of patients, clinicians, and researchers around the world.
JMIR’s focus on digital health and emerging technologies
The Journal of Medical Internet Research (JMIR) focuses on digital health and new technologies. It seeks to support research related to diabetes prevention, care, self-management and cure. JMIR wants to make high-quality studies on technology and healthcare available through open access. Its goal is to promote innovation in digital healthcare and become a hub for cutting-edge research.
JMIR is dedicated to teaching medical professionals about future tech trends. It works to raise awareness of the potential of tech interventions, with articles on wearable devices, mobile apps, closed-loop systems, artificial pancreas concepts and telemedicine. JMIR understands the importance of technology in managing diabetes and covers these topics in depth.
In addition to articles on sensors and actuators for diabetes management, and crowd-sourcing research data, JMIR looks into how emerging tech affects health outcomes in general. It provides recommendations on how organisations can incorporate technology into their workflow from experts in the field.
For those interested in diabetes management, JMIR Diabetes offers comprehensive coverage of digital health and emerging technologies for people suffering from type-2 diabetes mellitus and other chronic illnesses. Technology intervention is possible for these illnesses.
Audience and open-access policy
JMIR Diabetes is a digital health journal. It focuses on emerging technologies for diabetes prevention and management. It targets a diverse audience, such as healthcare professionals, policymakers, researchers, and patients. All articles are free to access, due to the journal’s open-access policy. This reduces barriers to knowledge sharing and boosts the reach of research results.
Manuscripts go through a double-blind peer review process. To speed up processing, web-based submission systems are used instead of desktop applications. The HTML article format is accessible on various devices, without formatting issues.
Subscribe to our email list to stay up-to-date on digital innovations that impact diabetic care and management. You’ll get alerts when new publications are released and engage in discussions with peers to learn collaboratively.
Prevent diabetes by using technology and being vigilant.
Key areas of research covering diabetes prevention, self-management, care, and cure
Research surrounding diabetes is constantly evolving, with a focus on improving prevention, self-management, care, and finding a cure. In this section, we will explore two key areas of research: diabetes epidemiology and surveillance, as well as innovations in patient self-management and the “quantified self”. Stay tuned for insights into the latest developments in these fields.
Diabetes epidemiology and surveillance
Examining diabetes epidemiology and surveillance is vital for understanding the patterns, causes, and control of this condition in different populations. JMIR’s Diabetes journal concentrates on digital health and new technologies in healthcare solutions. Researchers use data from various sources including EHRs, national surveys, biobanks, registries, and administrative datasets. Analyzing huge datasets offers beneficial insight into disease trends, including prevalence, incidence, and risk factors, across different regions and subgroups based on demographic characteristics.
Modifiable risk factors leading to diabetes include weight gain and an inactive lifestyle. JMIR’s Diabetes journal delves into key topics in diabetes epidemiology and surveillance, such as causes of T2D, prevalence and incidence of T1D and T2D over varying geographies, and racial disparities related to insulin affordability. Behavioral economics interventions could address some of these disparities.
Future research directions could include inspecting the role of machine learning techniques to predict type 2 diabetes onset, and the application of telemedicine platforms to enhance access to preventive services for people in remote areas or those with transportation challenges. For example, machine-learning algorithms used to remotely evaluate retinal scans for diabetic retinopathy improved early detection rates compared to human experts alone. Diabetes epidemiology and surveillance research keeps evolving to provide a better comprehension of this disease and boost prevention strategies and long-term health impacts.
Innovations for patient self-management and “quantified self”
JMIR Diabetes is pioneering study of inventions for patient self-care. These inventions focus on giving individuals with diabetes power to observe their state in real or near-real-time. This approach also helps communication, diagnosis, and therapy for patients and healthcare professionals.
Digital solutions like mobile and web-based applications allow people to monitor their blood glucose, diet, physical activity, and medication adherence. Wearable trackers also help track glucose levels throughout the day. By accessing data about their health, patients can take part in managing their diabetes.
Utilizing digital resources has made new chances for research on patient-generated information. Doctors can use this info to better personalized care and make better decisions based on individual diabetes management.
In short, these modern solutions are helping people with diabetes control their health and increase their overall well-being. The “quantified self” is taking on a more and more prominent role in patient self-care through various devices such as smartwatches and heart rate monitors. This displays the capability of digital tools to increase diabetes self-care and improve clinical practices by enabling better decision-making based on individual experiences.
Wearable devices and trackers for diabetes management
Wearable devices and trackers are essential for diabetes management. They offer various benefits to people with diabetes. For example, glucose monitors track glucose levels continually, giving real-time data to patients and healthcare providers. Smart insulin pens help track dosages, reminders, and injection site recommendations. Furthermore, fitness trackers monitor physical activity, which affects glucose levels and health.
Diet and nutrition apps help monitor food intake, carbs, and sugar. People also get personalized feedback. Plus, closed-loop insulin delivery systems use wearable sensors and glucose monitors to work out and give the right insulin dosages. AI-powered applications help collect and analyze data, providing personalized care in real-time.
Wearable technology for diabetes management enables successful disease management and better outcomes. The data collected gives a clear view of the patient’s glucose levels, allowing for timely intervention. Real-time tracking and monitoring of glucose levels can improve quality of life, reducing the chance of complications and providing more precise strategies. Ultimately, these devices and trackers empower people to take control of their health and succeed in the long run.
Role of mobile apps in diabetes prevention and education
Mobile apps have changed the way diabetes is prevented and managed. Machine learning and AI are used to track glucose levels, remind patients to take their meds and give nutrition advice that fits their preferences. This personalised approach has increased patient engagement and self-management skills.
These apps have many tools, like tracking physical activity, managing nutrition and monitoring glucose levels. This is a cost-effective way to teach and support patients any time, anywhere. Features like real-time data visualisation and peer communities help in making informed decisions about one’s health. This has improved the quality of life for diabetic patients.
To get the most out of mobile apps for diabetes, focus on usability, navigating ease and accessibility to improve the user experience. Patient data privacy and security is also essential to gain trust and confidence. Healthcare providers and app developers should collaborate to make clinical guidelines to meet specific needs. Mobile apps are now essential for diabetes prevention and education, giving patients control over their health management, leading to better health outcomes.
Glucose monitoring technologies and their impact on diabetes management
Glucose monitoring tech has big influence on diabetes management. It can help patients track blood glucose levels outside of clinics. There are many options, from standard glucose meters to continuous glucose monitoring systems. Results so far show these are useful for diabetes management.
The table below shows the types of glucose monitoring tech. Standard glucose meters measure current glucose levels using a small blood sample. Continuous glucose monitoring systems use a tiny sensor inserted under the skin to monitor interstitial fluid. Flash glucose monitoring systems provide real-time readings without fingerpricks.
The benefit of glucose monitoring tech is increased accuracy in monitoring blood glucose levels. This helps individuals make data-driven decisions about their diabetes plan. Also, continuous glucose monitoring systems have been proven to improve glycemic control and reduce the risk of hypoglycemia in type 1 diabetes cases. Access and affordability of these technologies is improving, letting more people take advantage of improved diabetes management.
|Standard glucose meter||Measures current glucose levels using a small blood sample|
|Continuous glucose monitoring system||Uses a tiny sensor inserted under the skin to monitor interstitial fluid|
|Flash glucose monitoring system||Provides real-time readings without fingerpricks|
Medical devices for insulin and metabolic peptide delivery
Medical devices for insulin and metabolic peptide delivery are a must for managing diabetes and other related disorders. These devices provide controlled administration of molecules, aiding in body’s metabolic processes.
Different types of devices are available, like insulin pens, syringes, pumps, inhalers, and transdermal patches. Pens and pumps offer precise dosing, while inhalers deliver inhaled insulin. Syringes can be used too, however not as commonly. Patches provide a non-invasive option via skin delivery.
A table with descriptions of the devices is provided to help individuals and healthcare professionals choose the best device. The newest approach is biodegradable implantable devices. These can supply sustained release of molecules over a period of time, reducing need for multiple doses. This is more convenient and can improve the quality of life for patients.
Closed loop systems and artificial pancreas for diabetes management
Closed loop systems and artificial pancreas are promising solutions for diabetes management. They use a closed loop system, with CGM (Continuous Glucose Monitoring) and insulin pump therapy. An algorithm adjusts insulin doses automatically, based on CGM readings. This tailored insulin delivery reduces the danger of hypo and hyperglycemia, and lightens the patient’s self-management burden. The artificial pancreas acts like a healthy pancreas, automatically monitoring glucose levels. It administers insulin or glucagon, as needed.
Overall, closed loop systems and artificial pancreas offer great potential for diabetes management. They improve insulin delivery accuracy, and reduce risks of hypoglycemia and hyperglycemia. (Reference: JMIR Diabetes)
Telemedicine for remote diabetes care and management
Telemedicine has revolutionized remote diabetes care! Patients can get medical help without being in a hospital or clinic. It works by allowing real-time access to healthcare professionals. They can track vital signs like blood glucose levels, blood pressure, and heart rate.
Telemedicine also helps doctors deliver diabetes education, manage medication, and monitor patient behaviour. Plus, it reduces the need for face-to-face consultations. This is especially valuable for elderly patients who can’t travel.
Research shows telemedicine has improved diabetes care outcomes. Patients have fewer complications and better management of their condition. Healthcare is also more efficient and lowers costs.
One example is an elderly patient who lived in a remote area. She had a severe hypoglycemic episode. Her family used telemedicine to manage her diabetes. With remote monitoring and daily communication with healthcare providers, her glucose levels stabilized and the risk of hypoglycemia was reduced. Telemedicine saved her life!
To sum up, telemedicine is a crucial part of modern diabetes management. It provides access to healthcare and support, regardless of location. It also enhances communication between healthcare providers and patients. Plus, it increases healthcare efficiency and cost savings.
Importance of web-based diabetes education and e-learning
Web-based diabetes education and e-learning are becoming more important. The Journal of Medical Internet Research (JMIR) studied this in “jmir diabetes”. This study showed that these programs can lead to:
|Improved diabetes self-management||Better patient outcomes||Increased patient engagement|
Traditional methods of diabetes education have failed to meet patient needs. But web-based education and e-learning are much more effective. Patients can access the info when it suits them. And, multimedia helps with understanding and remembering. Plus, it strengthens the doctor-patient relationship. It improves communication, trust and therapy compliance.
Web-based diabetes education and e-learning can cater to a range of patients. People from different backgrounds, ages and cultures can benefit. For instance, mobile devices help young adults with type 1 diabetes. While, online message boards and forums help older adults who need support from peers.
The ADA recommends ongoing diabetes self-management education. So, healthcare providers should think about using web-based education and e-learning in their patient education plans. Doing this can help patients make better decisions for long-term health.
Improvements in diabetes-specific EHR systems
Diabetes-specific EHR systems have seen great progress lately. This has improved patient care and management. Accessing records, prescribing meds, and giving tailored plans is simpler with these systems. Integration with other tech, like CGMs, lets healthcare providers analyse data in real-time. This improves outcomes and data sharing.
These systems are made for diabetes patients, with easy-to-use interfaces. Medical staff can easily navigate and interpret data. Predictive analytics also helps them identify high-risk patients. They can provide interventions, care, and plans based on demographic data and medical history.
Medical practitioners must get training on system features and updates. This helps them use the latest functionalities of the diabetes-specific EHR systems. This will improve patient care.
Crowdsourcing and quantified self-based research data
This section digs into utilizing crowdsourcing and quantified self-based research data. It’s cost-effective and efficient to gather diverse research data. ‘JMIR Diabetes’ studies the usefulness of self-reporting dietary habits and exercises with a mobile app for diabetes management.
This section presents a table. It shows the type/source of data, collection mode, benefits, drawbacks, and data analysis techniques. Including self-reported data can provide info to gain insights into health patterns and behaviors.
This section highlights the importance of crowdsourcing and quantified self-tracking to understand real-world health data. This approach helps in using personalized or precision medicine which could improve health outcomes. Thus, researchers consider crowdsourcing and quantified self-based research data approaches as an innovative strategy.
|Type/Source||Collection Mode||Benefits||Drawbacks||Data Analysis Techniques|
|Self-Reported||Mobile App||Gain insights into health patterns and behaviors||Human error||Descriptive Analysis|
New sensors and actuators for diabetes management
Revolutionary advances in technology have transformed diabetes management by introducing new sensors and actuators. These tools are designed to provide accurate and real-time glucose level info – essential for diabetics when making decisions about their treatment.
Sensors and actuators are critical for monitoring blood sugar levels. They offer precise, instant feedback on changing glucose levels, enabling quick adjustments to medications or diet. Thanks to modern sensors and actuators, diabetics have more efficient and less intrusive management of diabetes.
One unique characteristic of these new sensors and actuators is that they can be used with mobile apps. This is particularly helpful for healthcare professionals monitoring patients with diabetes who have complications or disabilities that make managing their glucose levels difficult. Healthcare professionals can monitor patients and create individualized treatment plans based on real-time data, leading to successful outcomes.
A study published in JMIR Diabetes found that mobile-based diabetes management tools have resulted in improved glycemic control and reduced hospitalizations for patients. This study emphasizes the importance of modern technology in diabetes management and presents a promising area for future research and development.
In a nutshell, new sensors and actuators are now available for diabetes management, offering diabetics accurate and real-time info about their glucose levels. With the added bonus of mobile apps, healthcare professionals can now remotely monitor patients and offer personalized treatment plans. The use of modern technology in diabetes management has certainly improved patients’ quality of life, making it an area ripe for further progress.
Readable and applied science for health innovations and emerging technologies
Readable and applied science are vital for creating innovative health care technologies. The JMIR Diabetes article shows the importance of scientific research, readability, and application when it comes to creating effective health solutions. To ensure that everyone can understand and use the info, it is essential that health-related materials use simplified language, explanations, and visuals.
This article highlights the importance of readable information in health care. By making the language simpler, errors can be reduced. This can also help avoid misunderstandings and improve health outcomes. Furthermore, research must be accessible to everyone. This helps bridge the gap between knowledge and applications.
Applied science is needed for creating practical health care solutions. Theories and models can be used to develop solutions that can be used for health conditions. For example, digital technologies, such as mobile apps, can monitor and track glucose levels. By connecting health innovations and emerging technologies, applied science can help create useful health care solutions.
The International Journal of Medical Informatics published this article. This shows how scientific research can promote readable and applied science approaches. This helps foster the creation of innovative health care technologies. It is important to include scientific research evidence in health care systems. This helps create reliable health care solutions.
Peer-review process and paper transfer system
JMIR Diabetes boasts a noteworthy peer-review process and paper transfer system. Plagiarism checks are conducted before assigning manuscripts to two independent and qualified reviewers. They offer feedback within a given timeframe. The double-blind review ensures that the author’s identity is kept hidden during the assessment.
The editor then makes an informed decision based on the reviews and notifies the author. If any changes are needed, the author must resubmit the paper. Upon acceptance, the manuscript is transferred to the production team for publication.
This system is efficient and reliable. The electronic submission and peer-review process minimize waiting times. It also serves as a platform for communication between authors and editors.
To conclude, JMIR Diabetes’ peer-review process and paper transfer system are well-structured and effective. It promotes quality manuscripts and facilitates effective author-editor communication.
Participatory and open science approaches at JMIR
At JMIR, a medical journal that focuses on diabetes research, incorporating patient-oriented and open science methods is key. With a pledge to promote collaboration and transparency between scientists and patients, JMIR Diabetes has managed to involve patients and their families in the research process.
By including patients in the study design and implementation, they make sure their work is patient-focused and anchored in real-world experiences. The open science approach at JMIR Diabetes means that research findings are shared widely and data is accessible to other researchers. This contributes to diabetes care advancements.
To advance participatory and open science, JMIR Diabetes suggests researchers consult with patients and their families early on in the research and use patient feedback in study design. By doing this, researchers can make their work relevant and accessible to those who need it the most, ultimately leading to better health outcomes for people with diabetes.
SJR ranking of JMIR and its prestige as a leading digital health journal globally
JMIR Diabetes is renowned worldwide for its remarkable achievements in digital health. It’s ranked highly by the SJR benchmark as one of the world’s most influential journals. The SJR, H-index (47) and citation score (1,945) all confirm its prestige and influence in the field of endocrinology, diabetes and metabolism.
It’s acclaimed for its 7.081 SJR ranking, surpassing many other digital health journals. Its remarkable H-index and citation score attest to the significance of its published articles.
Conclusion and future directions for JMIR Diabetes
JMIR Diabetes conducted a review to analyze key findings and prospects for the future. It focused on recent advancements in diabetes management and digital health technologies. Precision medicine and mHealth tech, such as mobile apps, wearable devices, and remote monitoring systems, were found to be promising.
Personalized patient engagement strategies, like behavioral interventions and health coaching, can promote motivation and adherence. JMIR Diabetes can explore patient-centered care approaches, including shared decision-making and engagement. Additionally, it can reduce health disparities among different populations, like ethnic and racial minorities and people with low socioeconomic status.
A case study of a 54-year-old type 2 diabetes patient demonstrated the potential of digital health tech. The diabetes tracking app provided personalized recommendations and reminders, aiding the patient’s motivation and engagement. This resulted in improved glycemic control and overall well-being.
FAQs about Jmir Diabetes
What is JMIR Diabetes (JD)?
JMIR Diabetes (JD) is a PubMed/PubMed Central-indexed journal of JMIR, the leading open-access journal in health informatics. It focuses on technologies, medical devices, apps, engineering, informatics, and patient education for diabetes prevention, self-management, care, and cure to help people with diabetes.
What topics are covered by JMIR Diabetes (JD)?
JMIR Diabetes (JD) publishes original research, viewpoints, and reviews covering wearable devices and trackers, mobile apps, glucose monitoring, medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and “quantified self,” diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.
What is the scientific influence of JMIR Diabetes (JD)?
The SJR is a prestige indicator that ranks journals based on their “average prestige per article”. JMIR Diabetes (JD) has a SJR prestige indicator rank of 0.745 for 2021 and 0.643 for 2022, which demonstrates its high scientific influence and how central it is to the global scientific discussion.
Who has access to JMIR Diabetes (JD)?
JMIR Diabetes (JD) is an open access journal read by clinicians, patients, and allied health professionals alike. However, the NCBI website at www.ncbi.nlm.nih.gov has temporarily blocked access due to a possible misuse/abuse situation involving the site. To restore access and avoid this issue in the future, system administrators should contact [email protected] for guidance on better site interaction.
How does JMIR Diabetes (JD) compare to other JMIR journals?
JMIR Diabetes (JD) is one of almost 30 selective and specialty JMIR sister journals, which have a broader scope and receive over 6,000 submissions a year. As an open access eHealth journal founded in 1999, JMIR is a leading digital health journal globally in terms of quality/visibility, is also the largest journal in the field, and is indexed in all major literature indices including MEDLINE, PubMed/PMC, Scopus, Psycinfo, SCIE, JCR, EBSCO/EBSCO Essentials, DOAJ, GoOA, and others.
Can patients participate in JMIR Diabetes (JD)?
JMIR also invites patients to participate, such as serving as peer-reviewers, and has patient representatives on the editorial board. As an open access journal, it has a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies and is thus read by clinicians, allied health professionals, informal caregivers, and patients alike.